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Background
Individuals with familial adenomatous polyposis (FAP)
require increased lifelong surveillance due to the high
risk of colorectal cancer and extracolonic features.
Despite the existence of well-established surveillance
guidelines, studies have shown that lack of patient
knowledge is a major hurdle to adherence. Patient edu-
cation conferences represent an avenue for patients to
obtain disease-specific information directly from experts.
There is a paucity of data addressing the educational
needs and characteristics of individuals who attend such
conferences and the impact on their FAP-related
knowledge.
Methods
Individuals with FAP identified through the institution’s
FAP registry and their family members were invited to
attend an educational conference. Adult attendees were
provided IRB approved baseline and follow-up surveys
as part of their conference packets. The paired surveys
were matched through the use of a unique survey iden-
tifier and contained items pertaining to demographic
and clinical history, FAP knowledge, and effectiveness of
the conference and presenters.
Results
Of the 50 conference attendees, 35 (70%) completed
baseline assessments, and 32 (64%) completed the post-
conference counterpart. Respondents’ median age was
51 (range: 24 72), and 66% were female. Nineteen (54%)
indicated that they had FAP, of which 12 (63%) had
undergone colorectal surgery. Fundic gland polyps, duo-
denal polyps, and desmoid tumors were present in
9 (47%), 11 (58%), and 3 (16%) affected participants,
respectively. Hepatoblastoma, duodenal cancer, and
osteomas were reported in 1 individual each. Regarding
surveillance, 14 (74%) and 13 (68%) of the affected
respondents received upper and lower GI surveillance at
least once every 3 years, respectively. Participants indi-
cated that among healthcare professionals, their primary
sources of information on FAP were primary care physi-
cians (n=15), surgeons (n=12) and/or genetic counselors
(n=13). Additional sources of information included
internet based resources (n=32), print materials (n=22),
and/or other individuals familiar with FAP (n=27).
Respondents scored on average 69% correct on a
14-item measure of FAP-related knowledge prior to the
conference; post-conference responses showed a statisti-
cally significant increase in mean scores (mean=77%,
p<0.05). Thirty-one of post-conference respondents
(97%) agreed or strongly agreed with items affirming
conference effectiveness. Most attendees stated that the
FAP conference provided them with information critical
to informed medical decision making. All respondents
stated a desire to attend future FAP conferences.
Conclusions
Conference attendees represented the wide clinical spec-
trum of FAP, with most adhering to high-risk surveil-
lance guidelines. While the majority of participants
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obtained their FAP-related information from the inter-
net, they may benefit from improved educational efforts
that encourage active participation in their own mainte-
nance and treatment of FAP. Future conferences should
be targeted to meet the broad range of patient interest
and knowledge in FAP-related topics.
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